Chloroquine Archives

Global COVID-19 prevention trial of hydroxychloroquine to resume

Antimalarial, Britain, Chloroquine, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Hydroxychloroquine, Medicines and Healthcare products Regulatory Agency (MHRA), Oxford University, R&D

A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.

June 30, 2020/by Reuters Health

718+ Pipeline Drugs Associated with COVID-19

Chloroquine, Clinical Data, Clinical Trials, Coronavirus Disease 2019 (COVID-19), FDA/Regulatory, GlobalData, Hospitalized COVID-19 Patients, Hydroxychloroquine, Product Pipelines, R&D, Remdesivir

New information released by GlobalData showed that there are now more than 718 pipeline drugs associated with COVID-19.

June 24, 2020/by BioSpace

AMA Doubles Down Against Off-Label Prescriptions, Despite Promising Evidence

American Medical Association (AMA), Antimalarial, Chloroquine, Coronavirus Disease 2019 (COVID-19), Hydroxychloroquine, Off-Label Use

The American Medical Association (AMA) doubled down on the organization’s stance against using off-label medicines such as hydroxychloroquine and chloroquine to treat COVID-19 patients.

April 10, 2020/by BioSpace

Pinpoint Therapeutics Targets COVID-19 With New Autophagy Pathway

Antimalarials, Autophagy, Cancer, Cancer Cells, Cells, Chloroquine, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, mTOR Pathway, Pathways, PPT1, R&D, Tumors

Pinpoint Therapeutics believes that the company’s approach to treat therapy-resistant cancers also may be effective against COVID-19.

April 2, 2020/by BioSpace